Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy.
Skeletal muscle atrophy is a feature of aging (termed sarcopenia) and various diseases, such as cancer and kidney failure. Effective drug treatment options for muscle atrophy are lacking. The tapeworm medication, niclosamide is being assessed for repurposing to treat numerous diseases, including end...
Guardado en:
Autores principales: | Hyun-Jun Kim, Ji-Hyung Lee, Seon-Wook Kim, Sang-Hoon Lee, Da-Woon Jung, Darren R Williams |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/89c2975d7c574f588b040eb29f9c4a79 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Exercise Training Attenuates Ovariectomy-Induced Alterations in Skeletal Muscle Remodeling, Apoptotic Signaling, and Atrophy Signaling in Rat Skeletal Muscle
por: Eun-Jeong Cho, et al.
Publicado: (2021) -
Active acetylcholine receptors prevent the atrophy of skeletal muscles and favor reinnervation
por: Bruno A. Cisterna, et al.
Publicado: (2020) -
Dkk3 dependent transcriptional regulation controls age related skeletal muscle atrophy
por: Jie Yin, et al.
Publicado: (2018) -
Depletion of HuR in murine skeletal muscle enhances exercise endurance and prevents cancer-induced muscle atrophy
por: Brenda Janice Sánchez, et al.
Publicado: (2019) -
Neural cell integration into 3D bioprinted skeletal muscle constructs accelerates restoration of muscle function
por: Ji Hyun Kim, et al.
Publicado: (2020)